Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma
Conditions: Esophageal Carcinoma; Neoadjuvant Therapy Interventions: Drug: Toripalimab; Drug: Anlotinib hydrochloride; Drug: Albumin paclitaxel; Drug: Cisplatin Sponsor: Nanfang Hospital, Southern Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research